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ABSTRACT 
Benzimidazole has attracted a great deal of importance due to their interesting chemistry and wide utility. Benzimidazole has wide 
range of uses and applications and is produced in great quantities throughout the world. The current research work was aim to 
evaluate the in vitro antifungal activity of series of benzimidazole derivatives. A series of benzimidazole derivatives were 
synthesized by reacting the various amine derivatives of o phenylene diame with carbon disulphide in presence of Potassium 
hydroxide. All the bis derivatives were characterized by IR, 1H NMR and chromatography method (TLC). The antibacterial activity 
was evaluated by their MIC and zone of inhibition of synthesized compounds by taking ciprofloxacin as reference standard. The 
microbiological assay revealed that the compounds show promising antibacterial activity. 
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INTRODUCTION 
Benzimidazole 
 
Historically, the first benzimidazole was prepared in 
1872 by Hoebrecker who obtained 2, 5 or 2, 6-
dimethylbenzimidazole by the reduction of 2-nitro-4-
methyl-acetanilide. Several years later Ladenburg 
obtained the same compound by refluxing 3, 4-
diaminotoluene with acetic acid. The benzimidazoles are 
also known as Benzimidazoles or Benzoglyoxalines. 
Benzimidazoles are weakly basic, being somewhat less 
basic than the imidazoles. Benzimidazoles are also 
sufficient acidic to be generally soluble in aqueous 
alkali and form N-metallic compounds. The acidic 
properties of benzimidazoles, like those of the 
imidazoles seen to be due to stabilization of the ion by 
resonance. Those compounds possessing unsubstituted -
NH grouping show molecular association through N-H-
N bonds. The dipole moment of benzimidazoles has 
been determined to be 3.93D (in dioxane) and 4.08D. 
The benzimidazole ring possesses a high degree of 
stability. Benzimidazole is neither affected by 
concentrated sulfuric acid when heated under pressure to 
270⁰C nor by vigorous treatment with hot HCl or with 
alkalis. Oxidation cleaves the benzene ring of 
benzimidazole only under vigorous conditions. The 
benzimidazole ring is also quite resistant to reduction; 
however, tetra hydro and hexahydro benzimidazoles can 
be prepared by catalytic reduction only under certain 
conditions. Benzimdazole is non- toxic and has little 
effect on the blood pressure. It is reported to reduce 
skeletal muscle tone by acting on the central nervous 
system and it also inhibit the growth of several yeasts 
and bacteria.
1,2 
Uses of Benzimidazole 
A large number of patents describe benzimidazole 
derivatives of use in the textile industry as wetting, 
emulsifying, foaming agents or as dispersants for use in 
dying. In the main, these compounds are sulfonated 
benzimidazoles. Another use is in the treatment of fibers 
to improve whiteness of the undyed material or as 
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optical bleach. A number of 2-aminobenzimidazoles 
have been used in the preparation of fluorescent dyes for 
use in such preparation as inks for making clothes to the 
dry cleaner. 
2-Mercaptobenzimidazole and several other 
benzimidazole derivatives have been found use in 
photographic industry. These compounds reduce 
photographic "Fog" and increase contrast and speed and 
hence have found use in photographic developing and 
fixing solutions. 2-mercaptobenzimidazoles has also 
found to be value as an antioxidant of rubber. Several 
benzimidazole derivatives have found use in the 
preparation of sun burn preventatives. These compounds 
protect the skin by absorbing ultraviolet rays. 
5-Methyl benzimidazole has been used as a camphor 
substitute. 2-methyl benzimidazole is said to be a value 
as a polymerization inhibitor and initiator in isoprene. 1-
piperdinomethyl benzimidazole has been used as a 
booster compound with antioxidants in rubber. A 
number of salts of benzimidazole sulfonic acid are said 
to be value in the preparations for the care of the mouth 
and teeth. 
Properties of Benzimidazole 
Benzimidazole with the imide nitrogen (i.e. hydrogen in 
the 1-position) is usually more soluble in polar solvents 
and less soluble in hot water but difficultly soluble in 
ether and insoluble in benzene. With the introduction of 
other non-polar substituent’s in various positions of the 
benzimidazole ring, the solubility in non-polar solvent is 
increased i.e. 2-methylbenzimidazole is easily soluble in 
ether. The polar group into the molecule increases 
solubility in polar solvents i.e. 2-aminobenzimidazole is 
soluble in water. 
 Benzimidazoles are weakly basic, being somewhat 
less basic then the imidazoles. 
 They are general soluble in dilute acids. 
 The more acidic benzimidazoles may be soluble in 
less basic solutions, such as potassium carbonate 
solution. 
 2(3H)-benzimidazolone is difficult to soluble in 
dilute sodium hydroxide solution. It is insoluble in 
dilute hydrochloric acid but is readily soluble in 
slightly warmed concentrated hydrochloric acid. 2-
benzimidazolecarboxylic acids are easily soluble in 
dilute acids. 
 The molecular weight of a number of 
benzimidazoles from freezing point data in 
naphthalene solution over a range of concentrations. 
Evidence was obtained indicating molecular 
association through N-H-N bonds in those 
compounds possessing an unsubsituted NH 
grouping. The strength of this bond is evidently 
enhanced by resonance of the benzimidazole 
nucleus. Those substances which are substituted in 
1-position by an alkyl, aryl, acyl or amino group are 
not highly associated. Substances such as 2-
benzoylbenzimidazole (1) occupy an intermediate 
position, being less highly associated then other 
benzimidazoles unsubstituted in the 1-position. It 
would appear that majority of the molecules possess 
the internal chelate structure (2). Such internal 
chelation is possible in a number of 2-substituted 
benzimidazole. 
N
H
N
COC6H5
     
N
N
C
O
H  
(1)                                               (2) 
 The dipole moment of benzimidazole have been 
determined, the values that have been obtaining 
3.93D (in dioxane) and 4.08D. 
 The melting point of a number of simple 
Benzimidazoles are: 
Benzimidazole     - 170⁰C 
1-methyl benzimidazole - 61⁰C 
2-methyl benzimidazole -176⁰C 
2-phenyl benzimidazole -294⁰C 
2(3H)-benzimidazolone - 308⁰C 
From this melting point it will be noted that the 
introduction of a substituent into the 1-position in 
general lowers the melting point. This appears to be due 
to the fact that benzimidazole containing hydrogen in 
the 1-position. 
Mechanism of Action
3
 
The primary action of the benzimidazole is associated 
with the ability of these drugs to bind to the protein 
tubulin and thus prevent tubulin polymerization to 
microtubules.  
Metabolism
4
 
The Benzimidazoles have been limited water solubility 
and as results are poorly absorbed from the GI tract (a 
fatty meal will increase absorption). Poor absorption 
may be beneficial since the drugs are used primarily to 
treat intestinal helminthes.  
Natural Products Containing Benzimidazole Nucleus 
The Benzimidazole nucleus does not appear to occur 
very widespread in nature. However, very recently the 5, 
6-dimethylbenzimidzole moiety has been shown to be 
part of the structure of vitamin B12. 
Vitamin B12 on acid hydrolysis leads to the formation of 
three closely related substances designated compounds 
α, β & γ. Component γ is 5, 6-dimethylbenzimidazole 
(1). 
N
H
NCH3
CH3
 
(1) 
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Component β is 5, 6-dimethyl-benzimidazole-1-α-D-
ribofuranoside (2). 
N
NCH3
CH3 OH
H H
OH
CCH2OH
O
 
(2) 
The α-component is probably a phosphorylated 
derivative of β-component. Since the α- component on 
acid hydrolysis yields the β-component and phosphate.  
 Biological Activities of Benzimidazole Derivatives 
 Antimicrobial Activity5, 6 
Purathchikody et al., synthesized benzimidazole 
derivatives were shown potent antimicrobial activity. 
N
N
R
X
X= CO-Ph etc.  
Guven et al., synthesized some novel phenyl and 
benzimidazole substituted benzyl ethers which show 
potent antimicrobial activity. 
MATERIALS AND METHODS 
All the chemicals used for synthetic work were 
purchased from Central drug house Pvt. Ltd (CDH), Hi-
Media laboratories Pvt. Ltd. and MERCK.  Melting 
points were determined by using Veego microprocessor 
based programmable melting point apparatus in open 
capillaries and are uncorrected. The completion of the 
reaction was checked by thin layer chromatography 
(TLC) by using ‘silica gel G’ procured from MERCK 
and was coated on laboratory glass slides using 
Benzene:Ethylacetate (4:1) solvent system. TLC plates 
were visualized using iodine chamber or observed under 
UV light. IR spectra were recorded in cm
-1
 using KBr 
pellets on PERKIN ELMER spectrophotometer. 
1
H 
NMR spectra (in δ ppm) on BRUKER AVANCE II 400 
NMR spectrophotometer using CDCl3 solvent and TMS 
as internal standard. 
 Step 1: Synthesis of 2-Mercaptobenzimidazole (BK 
1) 
NH2
NH2
+ CS2
KOH
Ethanol
o-phenylenediamine 2-Mercaptobenzimidazole
N
N
SH
H
 
Procedure 
Potassium hydroxide (1.9g, 0.03 moles) was dissolved 
in a mixture of ethanol (30 ml) and water (30 ml) in a 
250ml round bottom flask. To this, CS2 (2.7g, 0.03 
moles) was added with stirring. This mixture was boiled 
and then o-phenylenediamine (3.24g, 0.03 moles) was 
added to it. After refluxing the reaction mixture for 4 hr 
at 100.110C, cool the reaction mixture and was 
dissolved in water and the product was precipitated by 
the addition of dilute acetic acid (50%). The product was 
filtered and washed with water. It was recrystallized 
from ethanol.  
Appearance:                  Light brown 
M.F.:      C7H6N2S  
 Yield:       75%   
 Rf (CHCl3: CH3OH):            0.87 
M.P:       301-303⁰C 
I.R (KBr pellets): 3151.7 (Ar C-H), 1512.1 (C=C), 
1355.8 (C-N), 709.2 (C-S). 
NMR (DMSO):    7.06-7.16(m, 4H, Ar-H), 12.41(s, 1H, 
NH).
 
 
Step 2: Synthesis of 2-substituted mercaptobenzimidazole 
(1) Synthesis of 2-benzyl mercaptobenzimidazole  (BK2)                          
+
N
N
SH
H
2-MBI
Cl
Na
DMF, Methanol
N
N
S CH2
H
Benzyl chloride 2-Benzyl MBI
 
Procedure  
In a 250ml beaker, 2-mercapto benzimidazole (0.75g, 
5mmol) in dry N, N-dimethylformamide (8ml) was 
added to a solution of sodium (0.12g, 5 m mol) in dry 
methanol (2.5ml). After 10 min of stirring at room 
temperature, a benzyl chloride (0.63g, 5 m mol) was 
added in 2-3 portions, and the resultant suspension was 
stirred for 5h. The reaction mixture was then poured into 
an ice bath and left at overnight. The solid was filtered 
off, washed with cold water and air-dried. It was 
recrystallized from methanol. 
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Appearance:    White 
M.F.:     C14H12N2S  
Yield:     70%   
Rf (CHCl3: CH3OH):   0.75 
M.P:     179-181⁰C 
IR (KBr pellets): 3435.7(N-H), 3048.33(Ar C-H), 2963.21(C-H), 1511.88(C=C), 1350.05(C-N), 699.08(C-S). 
NMR (DMSO): 4.57 (s, 2H, CH2), 7.14-7.65 (m, 9H, Ar-H). 
(1) Step 3: Synthesis of 2-(p-nitro) benzyl mercaptobenzimidazole (BK3) 
+
N
N
SH
H
2-MBI
Br
NO2
Na
DMF, Methanol N
N
S CH2
H
NO2
2-(p-nitro) benzyl MBI
P-nitro benzyl 
    bromide
 
Procedure 
In a 250ml beaker, 2-mercapto benzimidazole (0.75g, 
5mmol) in dry N, N-dimethylformamide (8ml) was 
added to a solution of sodium (0.12g, 5 mmol) in dry 
methanol (2.5ml). After 10 min of stirring at room 
temperature, a p-nitro benzyl bromide (1.08g, 5 mmol) 
was added in 2-3 portions, and the resultant suspension 
was stirred for 6h. The reaction mixture was then poured 
into an ice bath and left at overnight. The solid was 
filtered off, washed with cold water and air-dried. It was 
recrystallized from methanol. 
Appearance:                   Light brown 
M.F.:       C14H11N3O2S  
Yield:       68%   
Rf (CHCl3: CH3OH):             0.70 
M.P:      183-186⁰C 
IR (KBr pellets): 3401.23(N-H), 3085.15 (Ar C-H), 
2959.12 (C-H), 1478.80 (C=C), 1361.22 (N=O), 
1349.40 (C-N), 700.50 (C-S). 
NMR (DMSO): 4.66(s, 2H, CH2), 7.10-8.12(m, 8H, Ar-
H). 
Antibacterial Activity 
The antibacterial activity of newly synthesized 
compounds was evaluated against Gram +ve bacteria i.e. 
Staphylococcus aureus and Bacillus subtilis, Gram –ve 
bacteria i.e. Escherichia coli. Ciprofloxacin was used as 
a standard drug.  
Preparation of Nutrient Agar Medium 
1. Peptic digest of aminal   tissue 5gm 
2. Sodium chloride 5gm 
3. Beef extract 1.50 gm 
4. Yeast extract 1.50 gm 
5. Agar 15 gm 
6. Distilled water 1000 ml 
 
All the ingredients were dissolved in distilled water; 
Adjust the pH to 8.0-8.4 with 5M NaOH solution and 
boil for 10-15 min. filtered the solution. Adjust the pH 
of the medium by 7.4±0.2 by the addition of dil. HCl. 
Sterilized the medium in autoclave for 15 min. at 121⁰C. 
Preparation of Test Solution 
The solution of the various benzimidazole derivatives in 
concentration of 100 μg was prepared in DMSO. 
Preparation of Standard Solution 
Weigh 10mg of standard drug and diluted to 10ml to 
form 1000 μg/ml of stock solution. From this stock 
solution, we took 1ml and diluted to 10ml to form 100 
μg/ml of standard solution. 
Procedure 
Inoculate a previously liquefied medium appropriate to 
the assays, with requisite quantity of suspension of the 
microorganism; add the suspension to the medium at 
temp. 40-50⁰C and immediately pour the inoculated 
medium into Petri dishes to give a depth of 3-4 min. 
Ensures that the layer of the medium are uniform in 
thickness by placing the dishes on the level of surface. 
Made few cavities on the surface of medium. Poured the 
solution of known concentration of the standard 
preparation and test preparation to cavities by means of 
micropipette in a sterile condition. Leave the dishes 
standing for 1-4 hrs in refrigerator as appropriate as a 
period of pre incubation diffusion to minimize the 
effects of variation in time between the applications of 
different solution. Incubate them for about 24 hrs at the 
temp. indicated. Accurately measured the diameter of 
zone of inhibition.  
Observation 
Observe the zone of inhibition by visually. 
RESULT AND DISCUSSION 
The compounds were evaluated in vitro antibacterial 
activity against Staphylococcus aureus, Bacillus subtilis, 
and Escherichia coli using Ciprofloxacin as standard. 
The zone of inhibition of the synthesized compounds 
against Staphylococcus aureus, Bacillus subtilis, and 
Escherichia coli is presented in table I. 
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Table I: Data of Antibacterial Activity of synthesized compounds 
 
S.No. 
 
Compounds 
Zone of inhibition in mm 
Staphylococcus   
aureus 
Bacillus subtilis Escherichia coli 
1. BK-1 05 12 08 
2. BK-2 13 11 0 
3. BK-3 14 19 17 
4. Ciprofloxacin 25 28 24 
 
CONCLUSION 
Three 2-substituted benzimidazole derivatives were 
synthesized and evaluated for their antibacterial activity. 
Derived compounds shows moderate antibacterial 
activity 
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